Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab. (2013). Journal of Analytical Oncology, 2(4),  218-225. https://doi.org/10.6000/1927-7229.2013.02.04.4